Schulman (SHLM) Tops Q4 EPS by 4c, Sales Top Expectations
Tweet
Share
E-mailGet Alerts SHLM Hot Sheet
Join SI Premium – FREE
Schulman (NASDAQ: SHLM) reported Q4 adjusted EPS of $0.49, $0.04 better than the analyst estimate of $0.45. Revenue for the quarter came in at $578.1 million versus the consensus estimate of $565.6 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
- Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
